URBANI, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 950
EU - Europa 416
AS - Asia 140
AF - Africa 40
Totale 1.546
Nazione #
US - Stati Uniti d'America 938
SE - Svezia 199
IT - Italia 126
CN - Cina 57
SG - Singapore 49
BG - Bulgaria 34
DE - Germania 30
CI - Costa d'Avorio 24
VN - Vietnam 23
SN - Senegal 15
CA - Canada 12
GB - Regno Unito 10
FI - Finlandia 8
FR - Francia 5
IN - India 5
HK - Hong Kong 3
BE - Belgio 1
IE - Irlanda 1
LK - Sri Lanka 1
MA - Marocco 1
PH - Filippine 1
PT - Portogallo 1
TR - Turchia 1
UA - Ucraina 1
Totale 1.546
Città #
Woodbridge 184
Fairfield 117
Houston 98
Chandler 78
Ann Arbor 64
Ashburn 59
Seattle 59
Wilmington 38
Cambridge 36
Beijing 34
Sofia 34
New York 33
Florence 32
Milan 30
Abidjan 24
Bremen 16
Princeton 16
Dakar 15
Lawrence 15
Pisa 15
Medford 14
Des Moines 11
Ottawa 11
Frankfurt am Main 10
Serra 10
Singapore 8
Lancaster 7
Nanjing 7
Zhengzhou 7
Changsha 5
Dong Ket 5
Falls Church 5
Marseille 4
Pune 4
Redwood City 4
Venturina 4
Dearborn 3
Hong Kong 3
San Diego 3
Auburn Hills 2
Council Bluffs 2
Grafing 2
Kent 2
Los Angeles 2
Lucca 2
Ogden 2
Phoenix 2
Redmond 2
Rome 2
Sovicille 2
Vicopisano 2
Albissola Marina 1
Bari 1
Boardman 1
Brussels 1
Düsseldorf 1
Izmir 1
Jiaxing 1
Jinan 1
Kunming 1
London 1
Marche 1
Norwalk 1
Rabat 1
Shenyang 1
Simi Valley 1
Southampton 1
Toronto 1
Totale 1.163
Nome #
Growth Hormone Is Necessary for the p53-Mediated, Obesity-Induced Insulin Resistance in Male C57BL/6J × CBA Mice 143
The presence of anti-thyroglobulin (TgAb) and/or anti-thyroperoxidase antibodies (TPOAb) does not exclude the diagnosis of type 2 amiodarone-induced thyrotoxicosis 126
Comparison of the effects of primary somatostatin analogue therapy and pituitary adenomectomy on survival in patients with acromegaly: a retrospective cohort study 125
Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET 119
Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET 117
Comparison Between Total Thyroidectomy and Medical Therapy for Amiodarone-Induced Thyrotoxicosis 109
Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitis 106
The beneficial effect of acromegaly control on blood pressure values in normotensive patients 98
Diabetes mellitus induced by somatostatin analogue therapy is not permanent in acromegalic patients 97
null 94
Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features 92
Duration of Exposure to Thyrotoxicosis Increases Mortality of Compromised AIT Patients: the Role of Early Thyroidectomy. 79
null 57
Identification of Two Different Phenotypes of Patients with Amiodarone-Induced Thyrotoxicosis and Positive Thyrotropin Receptor Antibody Tests 56
PCB153 reduces apoptosis in primary cultures of murine pituitary cells through the activation of NF-κB mediated by PI3K/Akt. 54
DISEASE ACTIVITY AND LIFESTYLE INFLUENCE COMORBIDITIES AND CARDIOVASCULAR EVENTS IN PATIENTS WITH ACROMEGALY 41
Divergent effects of dioxin- or non- dioxin- Like polychlorinated biphenyls on the apoptosis of primary cell culture from the mouse dioxin pituitary gland 30
Are there country-specific differences in the use of pegvisomant for acromegaly in clinical practice? An analysis from ACROSTUDY 14
Identification of Two Different Phenotypes of Patients with Amiodarone-Induced Thyrotoxicosis and Positive Thyrotropin Receptor Antibody Tests 13
Global psychological assessment with the evaluation of life and sleep quality and sexual and cognitive function in a large number of patients with acromegaly: a cross-sectional study 13
Factors associated with disease control failure in acromegaly patients treated with pegvisomant: an ACROSTUDY analysis 3
Totale 1.586
Categoria #
all - tutte 4.526
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.526


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020283 25 14 16 18 26 32 33 29 32 29 21 8
2020/2021117 7 7 11 1 6 3 11 9 14 10 7 31
2021/2022253 3 5 3 33 51 28 6 10 20 8 32 54
2022/2023334 57 47 24 23 21 32 1 31 65 1 28 4
2023/2024187 6 17 31 15 21 48 10 8 2 2 10 17
2024/20257 7 0 0 0 0 0 0 0 0 0 0 0
Totale 1.586